The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subcutaneous (SC) isatuximab administration by an on-body delivery system (OBDS) in combination with pomalidomide-dexamethasone (Pd) in patients with relapsed/refractory multiple myeloma (RRMM): Interim phase 1b study results.
 
HANG QUACH
Consulting or Advisory Role - Amgen; Antengene; Celgene; CSL Behring; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Sanofi
Research Funding - Amgen; Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
 
Gurdeep Parmar
Consulting or Advisory Role - Janssen
 
Enrique Ocio
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Oncopeptides; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Oncopeptides; Pfizer; Sanofi; Takeda
Speakers' Bureau - Janssen-Cilag; Takeda
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen
 
H. Miles Prince
No Relationships to Disclose
 
Albert Oriol Rocafiguera
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi
Speakers' Bureau - Amgen; Celgene
 
Nobuhiro Tsukada
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Sanofi
 
Kazutaka Sunami
Honoraria - Bristol-Myers Squibb Japan; Celgene; Janssen; Ono Pharmaceutical; Sanofi
Research Funding - Abbvie (Inst); Astellas Amgen BioPharama (Inst); Bristol-Myers Squibb Japan (Inst); Celgene (Inst); Chugai Pharma (Inst); GlaxoSmithKline K.K. (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Sanofi (Inst); Takeda (Inst)
 
Pierre Bories
No Relationships to Disclose
 
Chatchada Karanes
Speakers' Bureau - Sanofi
Research Funding - Celgene; Sanofi
 
Sumit Madan
Consulting or Advisory Role - Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics
Research Funding - Harpoon Therapeutics; Sanofi
 
Dorothee Semiond
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
Patents, Royalties, Other Intellectual Property - Sanofi
 
Marlene Inchauspe
Employment - Sanofi
 
Sandrine Macé
Employment - Sanofi
 
Petra B. Musholt
Employment - Sanofi
 
Florence Suzan
Employment - Sanofi
 
Philippe Moreau
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; oncopeptides; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; oncopeptides; Sanofi